Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.33 USD | -5.95% | +2.85% | +190.40% |
05-15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
05-15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+190.40% | 1.15B | |
+10.91% | 115B | |
+12.33% | 106B | |
-4.32% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.80% | 17.56B | |
-40.50% | 17.32B | |
+6.41% | 14.03B | |
+31.44% | 12.13B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Truist Securities Lowers Price Target on Arcutis Biotherapeutics to $40 From $45, Maintains Buy Rating